Fig. 1.
TP53 mutational spectra in urothelial carcinomas. (A) TP53 mutations in DNA obtained from UUC in Taiwan (113 mutations). (B) TP53 mutations in DNA obtained from UUC in endemic regions of Bosnia, Croatia, and Serbia (62 mutations) (12). (C) TP53 mutations in urothelial carcinomas of the renal pelvis and ureter, worldwide (73 mutations) (16). (D) TP53 mutations in urothelial carcinomas of the renal pelvis, ureter, bladder, and nonspecified urinary organs, worldwide (696 mutations) (16).
